Vitamin D receptor agonists, cancer and the immune system: an intricate relationship

Luciano Adorini1, Kenn C Daniel, Giuseppe Penna

  • 1BioXell, 20132 Milano, Italy. Luciano.Adorini@bioxell.com

Insights

Vitamin D receptor agonists show anti-cancer effects but may hinder immunotherapy. Combining calcitriol with chemotherapy drugs like doxorubicin may be effective for superficial bladder cancer, minimizing systemic immune effects.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Vitamin D receptor (VDR) agonists exhibit anti-cancer properties like inhibiting cell growth and promoting apoptosis.
  • However, VDR agonists possess immunomodulatory effects that may counteract cancer immunotherapy goals.
  • Minimizing systemic immunomodulatory effects of VDR agonists is crucial for their therapeutic application in cancer.

Purpose of the Study:

  • To investigate the potential of VDR agonists in managing superficial bladder cancer.
  • To explore the synergistic effects of calcitriol (a VDR agonist) with doxorubicin or epirubicin in bladder cancer treatment.
  • To identify clinical settings where VDR agonists' immunomodulatory effects can be minimized.

Main Methods:

  • In vitro studies were conducted to assess the effects of calcitriol, doxorubicin, and epirubicin on bladder cancer cell proliferation.
  • Synergistic interactions between calcitriol and chemotherapeutic agents were evaluated.

Main Results:

  • A strong in vitro synergism was observed between calcitriol and doxorubicin or epirubicin in inhibiting bladder cancer cell proliferation.
  • These findings suggest a potential for combined therapy in superficial bladder cancer.

Conclusions:

  • Calcitriol in combination with doxorubicin or epirubicin demonstrates significant anti-proliferative effects on bladder cancer cells in vitro.
  • This combination therapy may offer clinical value for superficial bladder cancer, potentially by localizing treatment and minimizing systemic immunomodulatory effects.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...